Objective: A rare case of Complex Regional Pain Syndrome (CRPS) type I after myocardial infarction (MI) and significant comorbid illness with few treatment options for pain control was successfully managed with the placement of a spinal cord stimulator (SCS).
C
omplex Regional Pain Syndrome (CRPS) is one of the most difficult chronic pain conditions to treat. The etiology of this painful disease remains elusive. There have been many instances in which the onset of CRPS type I or reflex sympathetic dystrophy (RSD) followed minor injury. Over the years, many possible causes have been identified for the onset of CRPS type I, but the underlying mechanism as to how the injury initiates a chronic and refractory pain condition remains unclear. In a prospective study, Veldman et al. 1 found the most common causes for RSD were: 65% trauma (mostly fractures); 19% after surgery; and 10% without clear precipitant. In a more recent study, Birklein, et al. 2 studied 145 patients and found similar results: 41% of patients had a history of limb fracture, 32% had surgery or a soft tissue injury, and 9% had carpal tunnel surgeries.
Several mechanisms have been proposed, including an exaggerated inflammatory process 3 and sympathetic dysfunction. Other proposed mechanisms include both central and peripheral nervous system dysfunction. 4, 5 This has also been labeled a psychosomatic disorder. 6 The following is a clinical case of CRPS type I or RSD (based on International Association of the Study of Pain [IASP] criteria, 1994) 7 , with onset after a myocardial infarction (MI). The patient's CRPS type I was then treated successfully with a spinal cord stimulator. Our institutional human investigation committee has approved this case report.
Case Report
A 44-year-old male presented with constant, severe burning pain of his left upper extremity for 1 year. His pain extended from below his left elbow to his fingers and worsened with even slight movement of the hand or fingers. The distribution of his pain was in a circumferential manner (nondermatomal). He complained of extreme sensitivity of the overlying skin to light touch, and the dorsum of the forearm and hand was more sensitive than the ventral aspect. He also reported swelling and purplish color change of his fingers and hands.
His pain began in March 1998, with an episode of substernal chest pain and pain radiating to the left upper extremity. He had a similar episode the following night and was diagnosed with a non-Q wave MI. A coronary angiogram revealed 2-vessel disease, and successful angioplasty was performed. He denied any history of trauma or injury to his neck, left shoulder, or left upper extremity. He continued to have left upper extremity pain despite revascularization surgery, which was performed in October 1998. Because of his persistent left upper extremity pain, his cardiologist performed echocardiogram and exercise treadmill. They found good left ventricular function without any evidence of ongoing ischemia. As part of his work-up, electromyography (EMG) and nerve conduction studies revealed minor changes in the median nerve near the left wrist. A cervical magnetic resonance imaging (MRI) demonstrated mild degenerative changes of the spine. Other significant past medical history included diabetes mellitus, diagnosed 3.5 years earlier and treated with insulin for 1.5 years, and a 10-year history of idiopathic pulmonary fibrosis requiring supplemental oxygen via nasal cannula.
On presentation, physical examination revealed a middle-aged man with nasal oxygen supplementation, and his left forearm covered with a brace and protected by his right hand. After removing the brace, we found a slightly red and mildly edematous distal forearm, without any evidence of increased sweating. Also, there were no changes of nail or hair growth or any muscle wasting of the left forearm when compared with the right. Sensory and motor examination was limited secondary to pain, but clearly showed marked mechanical allodynia in a circumferential manner below the left elbow and extending to the fingers. Although there was no marked difference in measured temperature between the 2 hands, he experienced significant cold allodynia from ice. The remaining neurologic examination was unremarkable.
He was taking sustained release morphine sulfate (SRMS), 15 mg, and gabapentin, 300 mg, 3 times a day as prescribed by his primary care physician. At his initial visit a diagnosis of CRPS type I was made, and plans were developed to gradually increase gabapentin and SRMS. A stellate ganglion block was also performed using 5 mL local anesthetics (1:1 ratio of 1% lidocaine and 0.5% bupivacaine). The procedure was performed at the C6 level with continuous blood pressure, electrocardiogram (ECG), and pulse oximetry monitoring. He tolerated the procedure well, developing Horner's syndrome and raised temperature on the affected side without sensory and motor deficits. He experienced only 6 hours of moderate pain relief. Plans for repeated stellate ganglion block were abandoned due to the concern of unintentional pneumothorax (prior history of smoking for many years with possible hyperinflated lung apex) and ipsilateral phrenic nerve paralysis in this patient who was on supplemental oxygen. Instead, we elected to optimize SRMS and gabapentin and encourage participation in physical therapy (PT) over the next 3 months adding short-acting opioid prior to the PT. However, the patient suffered from dyspepsia and drowsiness without improvement of his pain. The patient and his family felt discouraged by the lack of improvement with medications. Facing limited treatment options, we proposed a spinal cord stimulator (SCS) trial. Routine psychologic evaluation revealed no psychiatric or personality disorder (other than poor compliance with insulin). Four months after his initial presentation, a SCS trial was arranged. A trial lead (Pisces Quad; Medtronic, Minneapolis, MN) was placed epidurally, approximately 2 mm left from the midline in an anteroposterior fluoroscopy view. The epidural space was accessed at C7-T1 and the lead tip was threaded to near the C3 level. Excellent coverage of the painful areas of the left forearm and hand were achieved with approximately 90% pain relief. After a 6-day trial with consistent 80% to 90% pain relief, the temporary lead was removed. Four weeks later, the same lead at the same level was placed and connected with an internal pulse generator (Itrel-3; Medtronic). After 2 years of follow-up, he continues to have more than 70% pain relief from spinal cord stimulation and does not take supplemental analgesics. He has been closely followed by his cardiologist, with no recurrent MI. He uses the stimulator 4 to 5 times a day for 1 hour and remains fairly pain free. He never returned to his previous job as a cook, but remains moderately active at home helping his wife. Shortness of breath is the primary limitation for his continued disability.
Discussion
Painful dystrophic changes involving the left arm following a symptomatic MI have been described as "post-infarctal sclerodactylia." 8 Dystrophic changes in the skin and cutaneous appendages after MI have also been described. 9 Casale et al. 10 followed 60 patients after a recent MI (Ͻ 2 months) for pain level and sympathetic tone in the left upper extremity. Ten percent had burning pain, dysesthesia described as a pins and needle sensation, and a feeling of extremity heaviness. Neurophysiologic tests performed to assess peripheral nerve integrity were normal. Interestingly, they found increased sympathetic tone (a decrease in the amplitude of fingertip plethysmographic wave) among patients reporting continued pain of their left arm after MI. The authors reported no evidence of dystrophic changes in the skin or cutaneous adnexa. The lack of dystrophic change was thought to be secondary to the patient's earlier presentation.
Whether the onset of CRPS type I in our patient is directly related to MI is uncertain. Although MI has been described as a precipitating cause of CRPS type I, there has been a paucity of cases reported in the literature. Both Veldman et al. 1 (1993) and Birklein et al. 2 (2000) found no case of RSD or CRPS-I associated with recent history of an MI. Our patient had no history of trauma or surgery prior to the onset of pain. Also, there was no history of neurologic deficit suggesting stroke that could lead to the clinical scenario of "shoulder-hand syndrome." He did have diabetes mellitus, but no signs or symptoms of symmetrical diabetic peripheral neuropathy. There was a clear temporal relationship between the onset of chest pain and the upper extremity pain. We did not establish the diagnosis of CRPS by 3-phase radionuclide bone scan or quantitative sensory testing. The clinical diagnosis was based purely on IASP diagnostic criteria. 7 After making the diagnosis of CRPS-I, there were few treatment options available primarily due to his comorbid illness. Despite revascularization surgery, his symptoms persisted without evidence of ongoing cardiac ischemia. Opioids and gabapentin were without benefit, but were associated with increased side effects. The stellate ganglion block was unhelpful. Systemic sympatholytic agents and other neuropathic pain medications, including sodium channel blockers, such as mexiletine or carbamazepine, and tricyclic antidepressants were not considered appropriate due to his cardiac status. The option of spinal cord stimulation was proposed because of reports of positive outcome from its use for RSD. [11] [12] [13] More recently, others have reported that SCS reduces pain intensity among RSD patients. [14] [15] [16] A complete coverage of the painful area of the extremity from SCS-induced paresthesia is considered essential for continued pain relief. The tip of the SCS leads should be placed between C2 to C6 to cover the upper extremity pain, including the shoulder area. [11] [12] [13] [14] [15] [16] The mechanism of action of SCS in patients with RSD is unknown. A proposed mechanism is functional sympathectomy from the epidural spinal cord stimulation. 12 Considering the invasive nature of this therapy, a successful trial was considered crucial. During the trial, the patient had excellent (Ͼ 80%) pain relief for 6 days. After the successful trial and facing very limited conservative options, we placed a permanent SCS, from which the patient experienced long-term benefit.
